Not Yet Recruiting
Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy
NCT07310186
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
Not specified